J Neurogastroenterol Motil.  2019 Jan;25(1):6-14. 10.5056/jnm18139.

Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker

Affiliations
  • 1Department of Gastroenterology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • 2Fellowship Training Center and Medical Education Center, Keio University School of Medicine, Tokyo, Japan. hsuzuki1201@gmail.com

Abstract

Proton pump inhibitors are commonly utilized for the treatment of gastric acid-related diseases, such as gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection, and for the prevention of low-dose aspirin or nonsteroidal anti-inflammatory drug-induced peptic ulcers. Vonoprazan is a first-in-class potassium-competitive acid blocker, which has distinct advantages compared to other conventional proton pump inhibitors in terms of the efficacy for acid suppression. Due to its strong gastric acid suppression capabilities, vonoprazan serves as an effective drug for the treatment of gastroesophageal reflux disease and H. pylori infection.

Keyword

Gastroesophageal reflux; Helicobacter pylori; Peptic ulcer; Potassium; Proton pump inhibitors

MeSH Terms

Aspirin
Gastric Acid
Gastroesophageal Reflux
Helicobacter pylori
Peptic Ulcer
Potassium
Proton Pump Inhibitors
Proton Pumps*
Protons*
Aspirin
Potassium
Proton Pump Inhibitors
Proton Pumps
Protons
Full Text Links
  • JNM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error